APO Research
Talk to an analyst

APO RESEARCH · REPORT

Penicillin and Streptomycin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Penicillin and Streptomycin Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchPenicillin and Streptomycin Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Penicillin and Streptomycin Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Penicillin and Streptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Penicillin and Streptomycin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Penicillin and Streptomycin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Penicillin and Streptomycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Penicillin and Streptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Penicillin and Streptomycin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Penicillin and Streptomycin market include Takeda Pharmaceutical, Johnson & Johnson, Merck, Eli Lilly, GlaxoSmithKline, Toyama Chemical, MiddleBrook Pharmaceuticals, Gilead Sciences and Astra Zeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Penicillin and Streptomycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Penicillin and Streptomycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Penicillin and Streptomycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Penicillin and Streptomycin market size, projected growth trends, production technologies, key applications, and end-use industries.

Penicillin and Streptomycin Segment by Company

Takeda Pharmaceutical

Johnson & Johnson

Merck

Eli Lilly

GlaxoSmithKline

Toyama Chemical

MiddleBrook Pharmaceuticals

Gilead Sciences

Astra Zeneca

Astellas Pharma

Penicillin and Streptomycin Segment by Type

Penicillin

Streptomycin

Penicillin and Streptomycin Segment by Application

Throat Infections

Meningitis

Tuberculosis Treatment

Penicillin and Streptomycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Penicillin and Streptomycin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Penicillin and Streptomycin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Penicillin and Streptomycin significant trends, drivers, influence factors in global and regions.

6. To analyze Penicillin and Streptomycin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Penicillin and Streptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Penicillin and Streptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Penicillin and Streptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Penicillin and Streptomycin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Penicillin and Streptomycin industry.

Chapter 3: Detailed analysis of Penicillin and Streptomycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Penicillin and Streptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Penicillin and Streptomycin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Penicillin and Streptomycin Industry Trends Table 2. Penicillin and Streptomycin Industry Drivers Table 3. Penicillin and Streptomycin Industry Opportunities and Challenges Table 4. Penicillin and Streptomycin Industry Restraints Table 5. Global Penicillin and Streptomycin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Penicillin and Streptomycin Revenue Share by Company (2021-2026) Table 7. Global Penicillin and Streptomycin Sales Volume by Company (k units) & (2021-2026) Table 8. Global Penicillin and Streptomycin Sales Volume Share by Company (2021-2026) Table 9. Global Penicillin and Streptomycin Average Price (US$/unit) of Company (2021-2026) Table 10. Global Penicillin and Streptomycin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Penicillin and Streptomycin Key Company Manufacturing Base & Headquarters Table 12. Global Penicillin and Streptomycin Company, Product Type & Application Table 13. Global Penicillin and Streptomycin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Penicillin and Streptomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Penicillin Table 18. Significant Companies of Streptomycin Table 19. Global Penicillin and Streptomycin Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Penicillin and Streptomycin Sales Volume by Type (2021-2026) & (k units) Table 21. Global Penicillin and Streptomycin Sales Volume by Type (2027-2032) & (k units) Table 22. Global Penicillin and Streptomycin Sales Volume Share by Type (2021-2026) Table 23. Global Penicillin and Streptomycin Sales Volume Share by Type (2027-2032) Table 24. Global Penicillin and Streptomycin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Penicillin and Streptomycin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Penicillin and Streptomycin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Penicillin and Streptomycin Sales Value Share by Type (2021-2026) Table 28. Global Penicillin and Streptomycin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Throat Infections Table 30. Significant Companies of Meningitis Table 31. Significant Companies of Tuberculosis Treatment Table 32. Global Penicillin and Streptomycin Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Penicillin and Streptomycin Sales Volume by Application (2021-2026) & (k units) Table 34. Global Penicillin and Streptomycin Sales Volume by Application (2027-2032) & (k units) Table 35. Global Penicillin and Streptomycin Sales Volume Share by Application (2021-2026) Table 36. Global Penicillin and Streptomycin Sales Volume Share by Application (2027-2032) Table 37. Global Penicillin and Streptomycin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Penicillin and Streptomycin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Penicillin and Streptomycin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Penicillin and Streptomycin Sales Value Share by Application (2021-2026) Table 41. Global Penicillin and Streptomycin Sales Value Share by Application (2027-2032) Table 42. Global Penicillin and Streptomycin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Penicillin and Streptomycin Sales by Region (2021-2026) & (k units) Table 44. Global Penicillin and Streptomycin Sales Market Share by Region (2021-2026) Table 45. Global Penicillin and Streptomycin Sales by Region (2027-2032) & (k units) Table 46. Global Penicillin and Streptomycin Sales Market Share by Region (2027-2032) Table 47. Global Penicillin and Streptomycin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Penicillin and Streptomycin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Penicillin and Streptomycin Sales Value Share by Region (2021-2026) Table 50. Global Penicillin and Streptomycin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Penicillin and Streptomycin Sales Value Share by Region (2027-2032) Table 52. Global Penicillin and Streptomycin Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Penicillin and Streptomycin Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Penicillin and Streptomycin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Penicillin and Streptomycin Sales by Country (2021-2026) & (k units) Table 57. Global Penicillin and Streptomycin Sales Market Share by Country (2021-2026) Table 58. Global Penicillin and Streptomycin Sales by Country (2027-2032) & (k units) Table 59. Global Penicillin and Streptomycin Sales Market Share by Country (2027-2032) Table 60. Global Penicillin and Streptomycin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Penicillin and Streptomycin Sales Value Market Share by Country (2021-2026) Table 62. Global Penicillin and Streptomycin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Penicillin and Streptomycin Sales Value Market Share by Country (2027-2032) Table 64. Takeda Pharmaceutical Company Information Table 65. Takeda Pharmaceutical Business Overview Table 66. Takeda Pharmaceutical Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Takeda Pharmaceutical Penicillin and Streptomycin Product Portfolio Table 68. Takeda Pharmaceutical Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Penicillin and Streptomycin Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Penicillin and Streptomycin Product Portfolio Table 78. Merck Recent Development Table 79. Eli Lilly Company Information Table 80. Eli Lilly Business Overview Table 81. Eli Lilly Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Eli Lilly Penicillin and Streptomycin Product Portfolio Table 83. Eli Lilly Recent Development Table 84. GlaxoSmithKline Company Information Table 85. GlaxoSmithKline Business Overview Table 86. GlaxoSmithKline Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. GlaxoSmithKline Penicillin and Streptomycin Product Portfolio Table 88. GlaxoSmithKline Recent Development Table 89. Toyama Chemical Company Information Table 90. Toyama Chemical Business Overview Table 91. Toyama Chemical Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Toyama Chemical Penicillin and Streptomycin Product Portfolio Table 93. Toyama Chemical Recent Development Table 94. MiddleBrook Pharmaceuticals Company Information Table 95. MiddleBrook Pharmaceuticals Business Overview Table 96. MiddleBrook Pharmaceuticals Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. MiddleBrook Pharmaceuticals Penicillin and Streptomycin Product Portfolio Table 98. MiddleBrook Pharmaceuticals Recent Development Table 99. Gilead Sciences Company Information Table 100. Gilead Sciences Business Overview Table 101. Gilead Sciences Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Gilead Sciences Penicillin and Streptomycin Product Portfolio Table 103. Gilead Sciences Recent Development Table 104. Astra Zeneca Company Information Table 105. Astra Zeneca Business Overview Table 106. Astra Zeneca Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Astra Zeneca Penicillin and Streptomycin Product Portfolio Table 108. Astra Zeneca Recent Development Table 109. Astellas Pharma Company Information Table 110. Astellas Pharma Business Overview Table 111. Astellas Pharma Penicillin and Streptomycin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Astellas Pharma Penicillin and Streptomycin Product Portfolio Table 113. Astellas Pharma Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Penicillin and Streptomycin Distributors List Table 117. Penicillin and Streptomycin Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Penicillin and Streptomycin Product Image Figure 2. Global Penicillin and Streptomycin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Penicillin and Streptomycin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Penicillin and Streptomycin Sales (2021-2032) & (k units) Figure 5. Global Penicillin and Streptomycin Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Penicillin and Streptomycin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Penicillin Image Figure 10. Streptomycin Image Figure 11. Global Penicillin and Streptomycin Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Penicillin and Streptomycin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Penicillin and Streptomycin Sales Volume Share by Type (2021-2032) Figure 14. Global Penicillin and Streptomycin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Penicillin and Streptomycin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Penicillin and Streptomycin Sales Value Share by Type (2021-2032) Figure 17. Throat Infections Image Figure 18. Meningitis Image Figure 19. Tuberculosis Treatment Image Figure 20. Global Penicillin and Streptomycin Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Penicillin and Streptomycin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Penicillin and Streptomycin Sales Volume Share by Application (2021-2032) Figure 23. Global Penicillin and Streptomycin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Penicillin and Streptomycin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Penicillin and Streptomycin Sales Value Share by Application (2021-2032) Figure 26. Global Penicillin and Streptomycin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Penicillin and Streptomycin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Penicillin and Streptomycin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Penicillin and Streptomycin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Penicillin and Streptomycin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Penicillin and Streptomycin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Penicillin and Streptomycin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Penicillin and Streptomycin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Penicillin and Streptomycin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Penicillin and Streptomycin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Penicillin and Streptomycin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Penicillin and Streptomycin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Penicillin and Streptomycin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Penicillin and Streptomycin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Penicillin and Streptomycin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Penicillin and Streptomycin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Penicillin and Streptomycin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin
  • Streptomycin
Applications
  • Throat Infections
  • Meningitis
  • Tuberculosis Treatment
Companies covered
  • Takeda Pharmaceutical
  • Johnson & Johnson
  • Merck
  • Eli Lilly
  • GlaxoSmithKline
  • Toyama Chemical
  • MiddleBrook Pharmaceuticals
  • Gilead Sciences
  • Astra Zeneca
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Penicillin and Streptomycin Sales Value (2021-2032)
  4. 1.2.2 Global Penicillin and Streptomycin Sales Volume (2021-2032)
  5. 1.2.3 Global Penicillin and Streptomycin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Penicillin and Streptomycin Market Dynamics
  1. 2.1 Penicillin and Streptomycin Industry Trends
  2. 2.2 Penicillin and Streptomycin Industry Drivers
  3. 2.3 Penicillin and Streptomycin Industry Opportunities and Challenges
  4. 2.4 Penicillin and Streptomycin Industry Restraints
3 Penicillin and Streptomycin Market by Company
  1. 3.1 Global Penicillin and Streptomycin Company Revenue Ranking in 2025
  2. 3.2 Global Penicillin and Streptomycin Revenue by Company (2021-2026)
  3. 3.3 Global Penicillin and Streptomycin Sales Volume by Company (2021-2026)
  4. 3.4 Global Penicillin and Streptomycin Average Price by Company (2021-2026)
  5. 3.5 Global Penicillin and Streptomycin Company Ranking (2024-2026)
  6. 3.6 Global Penicillin and Streptomycin Company Manufacturing Base and Headquarters
  7. 3.7 Global Penicillin and Streptomycin Company Product Type and Application
  8. 3.8 Global Penicillin and Streptomycin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Penicillin and Streptomycin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Penicillin and Streptomycin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Penicillin and Streptomycin Market by Type
  1. 4.1 Penicillin and Streptomycin Type Introduction
  2. 4.1.1 Penicillin
  3. 4.1.2 Streptomycin
  4. 4.2 Global Penicillin and Streptomycin Sales Volume by Type
  5. 4.2.1 Global Penicillin and Streptomycin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Penicillin and Streptomycin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Penicillin and Streptomycin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Penicillin and Streptomycin Sales Value by Type
  9. 4.3.1 Global Penicillin and Streptomycin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Penicillin and Streptomycin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Penicillin and Streptomycin Sales Value Share by Type (2021-2032)
5 Penicillin and Streptomycin Market by Application
  1. 5.1 Penicillin and Streptomycin Application Introduction
  2. 5.1.1 Throat Infections
  3. 5.1.2 Meningitis
  4. 5.1.3 Tuberculosis Treatment
  5. 5.2 Global Penicillin and Streptomycin Sales Volume by Application
  6. 5.2.1 Global Penicillin and Streptomycin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Penicillin and Streptomycin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Penicillin and Streptomycin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Penicillin and Streptomycin Sales Value by Application
  10. 5.3.1 Global Penicillin and Streptomycin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Penicillin and Streptomycin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Penicillin and Streptomycin Sales Value Share by Application (2021-2032)
6 Penicillin and Streptomycin Regional Sales and Value Analysis
  1. 6.1 Global Penicillin and Streptomycin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Penicillin and Streptomycin Sales by Region (2021-2032)
  3. 6.2.1 Global Penicillin and Streptomycin Sales by Region: 2021-2026
  4. 6.2.2 Global Penicillin and Streptomycin Sales by Region (2027-2032)
  5. 6.3 Global Penicillin and Streptomycin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Penicillin and Streptomycin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Penicillin and Streptomycin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Penicillin and Streptomycin Sales Value by Region (2027-2032)
  9. 6.5 Global Penicillin and Streptomycin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Penicillin and Streptomycin Sales Value (2021-2032)
  12. 6.6.2 North America Penicillin and Streptomycin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Penicillin and Streptomycin Sales Value (2021-2032)
  15. 6.7.2 Europe Penicillin and Streptomycin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Penicillin and Streptomycin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Penicillin and Streptomycin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Penicillin and Streptomycin Sales Value (2021-2032)
  21. 6.9.2 South America Penicillin and Streptomycin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Penicillin and Streptomycin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Penicillin and Streptomycin Sales Value Share by Country, 2025 VS 2032
7 Penicillin and Streptomycin Country-level Sales and Value Analysis
  1. 7.1 Global Penicillin and Streptomycin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Penicillin and Streptomycin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Penicillin and Streptomycin Sales by Country (2021-2032)
  4. 7.3.1 Global Penicillin and Streptomycin Sales by Country (2021-2026)
  5. 7.3.2 Global Penicillin and Streptomycin Sales by Country (2027-2032)
  6. 7.4 Global Penicillin and Streptomycin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Penicillin and Streptomycin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Penicillin and Streptomycin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Penicillin and Streptomycin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Penicillin and Streptomycin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Penicillin and Streptomycin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical
  2. 8.1.1 Takeda Pharmaceutical Company Information
  3. 8.1.2 Takeda Pharmaceutical Business Overview
  4. 8.1.3 Takeda Pharmaceutical Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Penicillin and Streptomycin Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Penicillin and Streptomycin Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Penicillin and Streptomycin Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Penicillin and Streptomycin Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 GlaxoSmithKline
  26. 8.5.1 GlaxoSmithKline Company Information
  27. 8.5.2 GlaxoSmithKline Business Overview
  28. 8.5.3 GlaxoSmithKline Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GlaxoSmithKline Penicillin and Streptomycin Product Portfolio
  30. 8.5.5 GlaxoSmithKline Recent Developments
  31. 8.6 Toyama Chemical
  32. 8.6.1 Toyama Chemical Company Information
  33. 8.6.2 Toyama Chemical Business Overview
  34. 8.6.3 Toyama Chemical Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Toyama Chemical Penicillin and Streptomycin Product Portfolio
  36. 8.6.5 Toyama Chemical Recent Developments
  37. 8.7 MiddleBrook Pharmaceuticals
  38. 8.7.1 MiddleBrook Pharmaceuticals Company Information
  39. 8.7.2 MiddleBrook Pharmaceuticals Business Overview
  40. 8.7.3 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MiddleBrook Pharmaceuticals Penicillin and Streptomycin Product Portfolio
  42. 8.7.5 MiddleBrook Pharmaceuticals Recent Developments
  43. 8.8 Gilead Sciences
  44. 8.8.1 Gilead Sciences Company Information
  45. 8.8.2 Gilead Sciences Business Overview
  46. 8.8.3 Gilead Sciences Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gilead Sciences Penicillin and Streptomycin Product Portfolio
  48. 8.8.5 Gilead Sciences Recent Developments
  49. 8.9 Astra Zeneca
  50. 8.9.1 Astra Zeneca Company Information
  51. 8.9.2 Astra Zeneca Business Overview
  52. 8.9.3 Astra Zeneca Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Astra Zeneca Penicillin and Streptomycin Product Portfolio
  54. 8.9.5 Astra Zeneca Recent Developments
  55. 8.10 Astellas Pharma
  56. 8.10.1 Astellas Pharma Company Information
  57. 8.10.2 Astellas Pharma Business Overview
  58. 8.10.3 Astellas Pharma Penicillin and Streptomycin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Astellas Pharma Penicillin and Streptomycin Product Portfolio
  60. 8.10.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Penicillin and Streptomycin Value Chain Analysis
  2. 9.1.1 Penicillin and Streptomycin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Penicillin and Streptomycin Sales Mode & Process
  6. 9.2 Penicillin and Streptomycin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Penicillin and Streptomycin Distributors
  9. 9.2.3 Penicillin and Streptomycin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst